Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Safety of Umbilical Cord-Mesenchymal Stem Cell (UC-MSC) Transplantation in Patients With Retinitis Pigmentosa

NCT05786287 is registered in ClinicalTrials.gov with PT. Prodia Stem Cell Indonesia as lead sponsor.

NCT NCT05786287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05786287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Safety of Umbilical Cord-Mesenchymal Stem Cell (UC-MSC) Transplantation in Patients With Retinitis Pigmentosa
Lead sponsor
PT. Prodia Stem Cell Indonesia
Phase
Observational
Overall status
Not yet recruiting
Start date
May 31, 2026
Completion date
September 30, 2027
Enrollment
18 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

retinitis pigmentosa